Changes in O-linked mucin-type glycosylation are observed in over 90% of breast cancers, as demonstrated, for example, by the expression of the Tn antigen [10] and the loss of core 2 glycans [11]; see below. This evidence concerns the gene MUC5AC and breast carcinoma.